| Terminated | Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Can NCT04044430 | University of California, San Francisco | Phase 1 |
| Unknown | Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites NCT04267575 | Jerome Canady, M.D. | N/A |
| Active Not Recruiting | Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer NCT04046445 | Amal Therapeutics | Phase 1 |
| Unknown | Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer NCT04113096 | The University of The West Indies | EARLY_Phase 1 |
| Completed | Elevated Platelet Count as Prognostic Factor in Colorectal Cancer With Synchronous Liver Metastases NCT03717519 | Azienda Ospedaliera Universitaria Integrata Verona | — |
| Completed | Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer NCT03154190 | Stanford University | N/A |
| Completed | A Retrospective Cohort Study Outcome of Treatment in Asymptomatic Stage 4 Colorectal Cancer NCT04334395 | Mahidol University | — |
| Completed | Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients NCT03222258 | Seoul National University Hospital | — |
| Terminated | Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemot NCT01934179 | Fox Chase Cancer Center | — |
| Completed | Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab NCT01814501 | John Hays | Phase 2 |
| Completed | Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer NCT01652196 | John Hays | Phase 2 |
| Completed | Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer NCT01191684 | City of Hope Medical Center | Phase 1 |
| Completed | Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With NCT01205022 | City of Hope Medical Center | Phase 1 |
| Completed | Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer NCT01294826 | Swedish Medical Center | Phase 1 |
| Terminated | Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Can NCT01238965 | University of Southern California | Phase 1 |
| Terminated | Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal NCT01285102 | Fox Chase Cancer Center | Phase 1 |
| Terminated | Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors NCT01233505 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Lin NCT01198548 | Roswell Park Cancer Institute | Phase 2 |
| Completed | RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors NCT01158274 | National Cancer Institute (NCI) | Phase 1 |
| Completed | RO4929097 in Treating Patients With Metastatic Colorectal Cancer NCT01116687 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) NCT01126346 | Wake Forest University Health Sciences | N/A |
| Completed | Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer NCT01105377 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surg NCT00835679 | National Cancer Institute (NCI) | EARLY_Phase 1 |
| Completed | Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer NCT01037790 | Abramson Cancer Center at Penn Medicine | Phase 2 |
| Completed | Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer NCT00826540 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Completed | Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That H NCT00942266 | Roswell Park Cancer Institute | Phase 2 |
| Completed | Oophorectomy Followed by Chemotherapy Versus Chemotherapy Alone in Colorectal Cancer Patients NCT01483443 | Gachon University Gil Medical Center | Phase 3 |
| Completed | Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorecta NCT00551421 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer NCT00504153 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Nec NCT00397384 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer NCT00397878 | National Cancer Institute (NCI) | Phase 2 |
| Completed | VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer NCT00407654 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressi NCT00138177 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer NCT00134069 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Ther NCT00645710 | City of Hope Medical Center | Phase 1 / Phase 2 |
| Completed | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidne NCT00101348 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer NCT00100841 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors NCT00089362 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or NCT00088933 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer NCT00087191 | National Cancer Institute (NCI) | N/A |
| Terminated | Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent NCT00070122 | National Cancer Institute (NCI) | Phase 3 |
| Terminated | Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Se NCT00070265 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer NCT00052585 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer NCT00041340 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Live NCT00026234 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer NCT00032110 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction NCT00030498 | National Cancer Institute (NCI) | Phase 1 |
| Completed | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid NCT00031681 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer NCT00028496 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorect NCT00023933 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With NCT00025337 | National Cancer Institute (NCI) | Phase 3 |
| Completed | SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer NCT00005818 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colo NCT00019760 | National Institutes of Health Clinical Center (CC) | Phase 2 |
| Completed | Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer NCT00003873 | National Cancer Institute (NCI) | Phase 3 |
| Withdrawn | Antineoplaston Therapy in Treating Patients With Colon Cancer NCT00003486 | Burzynski Research Institute | Phase 2 |